Oral bioavailability and pharmacokinetics of ciprofloxacin in patients with AIDS

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 7, 1997, Pages 1508-1511

  Owens Jr , Robert C ^a,b,c   Patel, Kalpana B ^d   Banevicius, Mary Anne ^e   Quintiliani, Richard ^e   Nightingale, Charles H ^e   Nicolau, David P ^e  

^a MEDICAL CENTER OF DELAWARE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^c UNIVERSITY OF THE SCIENCES   (United States)

^d LONG ISLAND UNIVERSITY   (United States)

^e HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG HALF LIFE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0343036270     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.7.1508     Document Type: Article

References (23)

1. Bartlett, J. G., P. C. Belitsos, and C. L. Sears. 1992. AIDS enteropathy. Clin. Infect. Dis. 15:726-735.
2. Berning, S. E., G. A. Huitt, M. D. Iseman, and C. A. Peloquin. 1992. Malabsorption of antituberculosis medications by a patient with AIDS. N. Engl. J. Med. 327:1817-1818.
3. Centers for Disease Control and Prevention. 1992. 1993 Revised CDC HIV classification system and expanded AIDS surveillance definition for adolescents and adults. Morbid. Mortal. Weekly Rep. 41:1-19.
4. Craig, W. A. 1995. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn. Microbiol. Infect. Dis. 22:89-96.
5. Demuria, D., A. Forrest, J. Rich, J. M. Scavone, L. G. Cohen, and P. H. Kazanjian. 1993. Pharmacokinetics and bioavailability of fluconazole in patients with AIDS. Antimicrob. Agents Chemother. 37:2187-2192.
6. Ehrenpreis, E. D., S. P. Gulino, B. K. Patterson, R. M. Craig, H. Yokoo, and A. J. Atkinson. 1991. Kinetics of D-xylose absorption in patients with human immunodeficiency virus enteropathy. Clin. Pharmacol. Ther. 49:632-640.
7. Gatti, G., J. Flaherty, J. Bubp, J. White, M. Borin, and J. Gambertoglio. 1993. Comparative study of bioavailabilities and pharmacokinetics of clindamycin in healthy volunteers and patients with AIDS. Antimicrob. Agents Chemother. 37:1137-1143.
8. Gillin, J. S., M. Shike, N. Alcock, C. Urmacher, S. Krown, R. C. Kurtz, C. J. Lightdale, and S. J. Winawer. 1985. Malabsorption and mucosal abnormalities of the small intestine in the acquired immune deficiency syndrome. Ann. Intern. Med. 102:619-622.
9. Goodwin, S. D., H. A. Gallis, and A. T. Chow. 1992. Pharmacokinetics of levofloxacin in HIV-infected patients, abstr. 322, p. 8. In Proceedings of the Fourth International Symposium on New Quinolones.
10. Greenson, J. K., P. C. Belitsos, J. H. Yardley, and J. G. Bartlett. 1991. AIDS enteropathy: occult enteric infections and duodenal mucosal alterations in chronic diarrhea. Ann. Intern. Med. 114:366-372.
11. Klepser, M. E., Z. Zhu, D. P. Nicolau, M. A. Banevicius, P. P. Belliveau, J. W. Ross, L. Broisman, R. Quintiliani, and C. H. Nightingale. 1996. Oral absorption of trimethoprim-sulfamethoxazole in patients with AIDS. Pharmacotherapy 16:656-662.
12. Kotler, D. P., A. Francisco, and F. Clayton. 1990. Small intestinal injury and parasitic disease in AIDS. Ann. Intern. Med. 113:444-449.
13. Kotler, D. P., H. P. Gaetz, M. Lange, E. B. Klein, and P. R. Holt. 1984. Enteropathy associated with the acquired immunodeficiency syndrome. Ann. Intern. Med. 101:421-428.
14. Krol, G. J., G. W. Beck, and T. Benham. 1995. HPLC analysis of ciprofloxacin and ciprofloxacin metabolites in body fluids. J. Pharm. Biomed. Anal. 14:181-190.
15. Macnab, K. A., M. J. Gill, L. R. Sutherland, A. Murphy, and R. Brant. 1996. Zidovudine absorption and small intestinal function in HIV seropositive patients. J. Antimicrob. Chemother. 37:825-829.
16. Macnab, K. A., M. J. Gill, L. R. Sutherland, N. De Boer Visser, and D. Church. 1993. Erratic zidovudine bioavailability in HIV seropositive patients. J. Antimicrob. Chemother. 31:421-428.
17. Madi, K., A. Trajman, and C. F. da Silva. 1991. Jejunal biopsy in HIV-infected patients. J. Acquired Immune Defic. Syndr. 4:930-937.
18. 17a. Owens, R. C., K. B. Patel, C. H. Nightingale, R. Quintiliani, M. A. Banevicius, and D. P. Nicolau. 1996. Oral bioavailability of ciprofloxacin in patients with acquired immunodeficiency syndrome, abstr. A8, p. 2. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
19. Patel, K. B., R. Belmonte, and H. M. Crowe. 1995. Drug malabsorption and resistant tuberculosis in HIV-infected patients. N. Engl. J. Med. 332:336-337.
20. Smith, P. D., H. C. Lane, V. J. Gill, J. F. Manischewitz, G. V. Quinnan, A. S. Fauci, and H. Masur. 1988. Intestinal infections in patients with acquired immunodeficiency syndrome (AIDS). Etiology and response to therapy. Ann. Intern. Med. 108:328-333.
21. Stass, H., W. Bianchi, J. Kuhlmann, F. Maggiolo, F. Sutter, and M. Tellarini. 1994. Pharmacokinetics of ciprofloxacin in AIDS patients suffering from opportunistic bacterial infections. Pharm. Res. 11(Suppl.):447.
22. Ullrich, R., M. Zeitz, W. Heise, M. L'age, G. Hoffken, and E. O. Reicken. 1989. Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy. Ann. Intern. Med. 111:15-21.
23. Vance-Bryan, K., D. R. P. Guay, and J. C. Rotschafer. 1990. Clinical pharmacokinetics of ciprofloxacin. Clin. Pharmacokinet. 19:434-461.